Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Alteogen Inc (196170 KS)
Watchlist
50
Analysis
Health Care
•
South Korea
Alteogen Inc. is a pharmaceutical research company. The Company researches and develops bio-medicines such as bio-better and bio-similar.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Alteogen Inc
•
27 Mar 2024 17:57
Alteogen: Block Deal Sale of About 3% of Shares
On 27 March, Alteogen announced that Jeong Hye-shin, former Alteogen Chief Strategy Officer (CSO), sold 1.6 million shares of Alteogen stock (3% of...
Douglas Kim
Follow
505 Views
Share
bullish
•
Alteogen Inc
•
23 Feb 2024 12:58
Alteogen (196170 KS): Modified License Agreement For Major Platform Technology Is A Hard Catalyst
Alteogen modifies license agreement with Merck, granting exclusive global rights for ALT-B4 for pembrolizumab for an upfront payment of $20M and...
Tina Banerjee
Follow
503 Views
Share
bullish
•
Quantitative Analysis
•
06 May 2024 07:05
KRX Foreign Holding Weekly (May 3rd): Celltrion, Sk Hynix
We analyzed KRX foreign holding data for the past week and highlighted foreign holding changes in Celltrion (068270 KS), Sk Hynix (000660 KS).
Ke Yan, CFA, FRM
Follow
119 Views
Share
bullish
•
Alteogen Inc
•
05 Jan 2024 09:30
Alteogen (196170 KS): First Proprietary Product Approval in Korea To Improve Revenue Visibility
Alteogen’s first proprietary recombinant human hyaluronidase liquid product, Tergase (ALT-BB4) is undergoing approval process in Korea and is...
Tina Banerjee
Follow
566 Views
Share
bullish
•
Alteogen Inc
•
19 Jun 2023 18:08
Alteogen (196170 KS): Milestone Payments and Pipeline Progress Strengthen Business Growth Prospect
Alteogen is well-position to reap the benefit (milestone payment) of outlicensing of its technology and is expected to turn profitable on triple...
Tina Banerjee
Follow
340 Views
Share
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.31.1
x